About CLST Holdings, Inc. (OTC: CLHI)
On March , , during a Special Meeting of Stockholders of CellStar Corporation the Company , holders of a majority of the Company s outstanding common stock voted to approve the sale of its U.S. and Mexico operations, the Liquidation and Dissolution proposal, and the amendment of CellStar s Certificate of Incorporation to change the corporate name to CLST Holdings, Inc. On April , , the Company formally changed its name to CLST Holdings, Inc. For more information on the Plan of Dissolution, please refer to the Proxy Statement filed by the Company on February , .
- Robert A. Kaiser / CEO
- Timothy Durham / Secretary
- Jerome A. Trojan III / Vice President, CFO, Treasurer
- Robert A. Kaiser / Chairman
Current Share Structure
- Market Cap: $74,243 - 03/12/2018
- Authorized: 200,000,000 - 11/30/2004
- Issue and Outstanding: 23,949,282 - 10/05/2010
- Float: 14,371,583 - 11/30/2005
Daily Technical Chart for (OTC: CLHI)
Stay tuned for daily updates and more on (OTC: CLHI)
More to come on (OTC: CLHI)
Do your DD and if you choose, be ready to go!
The Research: All source information contained in this email is from the public sources mentioned below.
Disclaimer: OTC Report publishes reports providing information on selected companies. OTC Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. OTC Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in CLHI is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. OTC Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. OTC Report does not own any shares of CLHI and does not buy, sell, or trade any shares of CLHI. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by OTC Report. All rights reserved. Our Full Disclaimer: http://otc.report/disclaimer/